期刊文献+

敲低吲哚胺2,3双加氧酶2基因抑制荷黑素瘤小鼠肿瘤生长并增强其免疫功能

Knockdown of indoleamine 2,3-dioxygenase 2 ( IDO2) gene inhibits tumor growth and enhances immune function in mice bearing melanoma
下载PDF
导出
摘要 目的以吲哚胺2,3双加氧酶2(IDO2)作为治疗靶标,研究IDO2基因表达在肿瘤治疗中的作用及其对免疫应答的影响。方法采用B16-BL6细胞株构建小鼠黑素瘤种植模型,以携带IDO2小干扰RNA的质粒(IDO2-shRNA)及对照组质粒(scramble-shRNA)尾静脉高压注射法治疗小鼠黑素瘤;游标卡尺测量肿瘤大小;流式细胞术检测各组引流淋巴结内调节性T细胞(Treg)百分比、T细胞凋亡百分比,以及脾脏内树突状细胞(DC)表面共刺激分子CD80、CD86表达情况;乳酸脱氢酶法检测CD8+T淋巴细胞杀伤肿瘤细胞的能力;ELISA检测血清内肿瘤坏死因子α(TNF-α)、γ干扰素(IFN-γ)的水平。结果 IDO2-shRNA治疗组肿瘤的形成时间较晚,肿瘤的生长速度缓慢,离体肿瘤质量明显减少;IDO2-shRNA治疗组引流淋巴结内的Treg减少,T细胞凋亡降低,脾脏DC表面共刺激分子CD80、CD86明显增加;CD8+T细胞杀伤B16-BL6的能力增强,血清内TNF-α、IFN-γ表达水平升高。结论敲低荷瘤小鼠体内IDO2可抑制黑素瘤生长,提高机体的抗肿瘤免疫反应。 Objective To study the role of indoleamine 2,3-dioxygenase 2( IDO2) in anti-tumor therapy and its effect on the immune response when using IDO2 as therapeutic target. Methods B16-BL6 cells were used to construct mouse xenografted melanoma model. IDO2-shRNA that contained IDO2-siRNA or control shRNA( scrambled-shRNA) was injected hydrodynamically via the tail vein to treat melanoma. The tumor size was measured by vernier caliper. Flow cytometry was performed to analyze the percentage of regulatory T cells( Tregs),T cell apoptosis rate in draining lymph nodes and the expressions of co-stimulatory molecules on splenic dendritic cells( DCs) from different treatment groups. The lactate dehydrogenase( LDH) assay was used to determine the CD8+cytotoxic T lymphocyte( CTL) activity. The serum levels of tumor necrosis factor α( TNF-α) and interferon γ( IFN-γ) were detected by ELISA. Results In the IDO2-shRNA treated group,the tumor formation time was delayed,tumor grew slowly,and excised tumor mass was significantly reduced. IDO2-shRNA treatment also decreased the percentage of Tregs and T cell apoptosis in draining lymph nodes and increased the expressions of co-stimulatory molecules CD80 and CD86 on splenic DCs. The capacity of CD8+T cells to kill B16-BL6 cells was enhanced and the serum levels of TNF-α and IFN-γ were upregulated. Conclusion Silencing IDO2 can effectively inhibit the growth of melanoma and improve the anti-tumor immune response in vivo.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2017年第12期1605-1609,共5页 Chinese Journal of Cellular and Molecular Immunology
基金 江西省教育厅科技项目(GJJ161152) 江西省重大科技创新研究项目(2012ACB00800) 江西科技学院科研启动经费(2016年)
关键词 吲哚胺2 3双加氧酶2(IDO2) 短发夹RNA(shRNA) 黑素瘤 静脉高压注射法 肿瘤免疫 IDO2 shRNA melanoma hydrodynamic injection tumor immunity
  • 相关文献

参考文献6

二级参考文献138

  • 1邱继刚,邱双健,吴志全.肿瘤患者的免疫状态指标[J].世界华人消化杂志,2004,12(6):1427-1431. 被引量:4
  • 2Matthews N, W.J. Tumour-necrosis factor from the rabbit. I. Mode of action, specificity andphysicochemical properties [J]. Br J Cancer, 1978, 38 (2): 302-309.
  • 3Green S, D.A., Chiasson MA. Murine tumor necrosis-inducing factor: purification and effects on myelomonocytic leukemia cells [J]. J Natl Cancer Inst, 1982, 68 (6): 997-1003.
  • 4BB, A. Signalling pathways of the TNF superfamily: a double-edged sword [J]. Nat Rev Immunol, 2003, 3 (9): 745-756.
  • 5Wang AM, C.A., Ladner MB, Lin LS, et al. Molecular cloning of the complementary DNA for human tumor necrosis factor [J]. Science, 1985, 228:149-154.
  • 6Van Horssen R, T.H.T., Eggermont AM. TNF-alpha in cancer treat- ment: molecular insights, antitumor effects, and clinical utility [J]. Oncologist, 2006, 11: 397-408.
  • 7Mu ller-Hermelink N, B.H., Pichler B, Wieder T, et al. TNFR1 signal- ing and IFN-gamma signaling determine whether T cells induce tu- mor dormancy or promote multistage carcinogenesis [J]. Cancer Cell, 2008, 13:507-518.
  • 8Calzascia T, P.M., Hall H, Sabbagh L, Ono N, Elford AR et al. TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice [J]. J Clin Invest, 2007, 117:3833-3845.
  • 9Moore RJ, O.D., Stamp G, Arnott C, et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis [J]. Nat Med,1999,5:828-831.
  • 10Suganuma M, O.S., Marino MW, Sakal A, et al. Essential role of tumor necrosis factor alpha (TNF-alpha) in minor promotion as revealed by TNF-alpha--deficient mice [J]. Cancer Research, 1999, 59:4516-4518.

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部